Web Watch

Share this article:
Marjorie Martin, SVP and general manager of Everyday Health, believes consumers will be the big winner in the merger of Revolution Health and Everyday Health. 

Prior to the merger, Everyday Health was the second most popular health website with 14.7 million unique visitors and more than 80 million page views. The Revolution Health Network sites were the third most popular health destination with 12 million unique visitors per month and 224 million page views. Media buyers tend to focus client's online budgets on a handful of targeted sites that deliver desired results. Now they can get almost twice the audience reach and frequency with one buy. 

WebMD has been the most popular health web destination for more than 10 years. According to comScore Media Metrics, WebMD has more than 17.7 million monthly site visitors and their website generates 206 million monthly page views. But it looks like there's a new sheriff in town. The Everyday Health Network is projected to deliver more than 20 million unique monthly visitors according to a comScore Plan Metrics custom study. 

Destination sites like WebMD, Everyday Health Network and HealthCentral Network will likely account for the lion's share of health display ad investments going forward. Google and, to a lesser extent, Yahoo! will share most of the health search dollars. It will be interesting to see if Google tries to establish a stronger foothold in the health space. If the decision comes down to whether Google continues to build up their existing health presence or buy one of the top players, they certainly have the money to succeed either way. It's just a matter of how wisely they spend it.

Dan McKillen is president of the HealthDay news service
Share this article:

Email Newsletters

More in Features

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.